본문 바로가기
KERD
논문KCI 등재

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea

김종헌|이순영|Choi Gawon|Lim Ah-Young|Choi Sojin|Park Kunhee
한국역학회 (Korean Society of Epidemiology)|2023.01|Epidemiology and Health|제45권 |pp. 1-9|DOI 10.4178/epih.e2023008

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

VaccinationSARS-CoV-2VariantsViral loadVirus shedding

초록

OBJECTIVES: We compared the viral cycle threshold (Ct) values of infected patients to better understand viral kinetics by vaccination status during different periods of variant predominance in Gyeonggi Province, Korea. METHODS: We obtained case-specific data from the coronavirus disease 2019 (COVID-19) surveillance system, Gyeonggi in-depth epidemiological report system, and Health Insurance Review & Assessment Service from January 2020 to January 2022. We defined periods of variant predominance and explored Ct values by analyzing viral sequencing test results. Using a generalized additive model, we performed a nonlinear regression analysis to determine viral kinetics over time. RESULTS: Cases in the Delta variant’s period of predominance had higher viral shedding patterns than cases in other periods. The temporal change of viral shedding did not vary by vaccination status in the Omicron-predominant period, but viral shedding decreased in patients who had completed their third vaccination in the Delta-predominant period. During the Delta-predominant and Omicron-predominant periods, the time from symptom onset to peak viral shedding based on the E gene was approximately 2.4 days (95% confidence interval [CI], 2.2 to 2.5) and 2.1 days (95% CI, 2.0 to 2.1), respectively. CONCLUSIONS: In one-time tests conducted to diagnose COVID-19 in a large population, although no adjustment for individual characteristics was conducted, it was confirmed that viral shedding differed by the predominant strain and vaccination history. These results show the value of utilizing hundreds of thousands of test data produced at COVID-19 screening test centers.

Abstract

OBJECTIVES: We compared the viral cycle threshold (Ct) values of infected patients to better understand viral kinetics by vaccination status during different periods of variant predominance in Gyeonggi Province, Korea. METHODS: We obtained case-specific data from the coronavirus disease 2019 (COVID-19) surveillance system, Gyeonggi in-depth epidemiological report system, and Health Insurance Review & Assessment Service from January 2020 to January 2022. We defined periods of variant predominance and explored Ct values by analyzing viral sequencing test results. Using a generalized additive model, we performed a nonlinear regression analysis to determine viral kinetics over time. RESULTS: Cases in the Delta variant’s period of predominance had higher viral shedding patterns than cases in other periods. The temporal change of viral shedding did not vary by vaccination status in the Omicron-predominant period, but viral shedding decreased in patients who had completed their third vaccination in the Delta-predominant period. During the Delta-predominant and Omicron-predominant periods, the time from symptom onset to peak viral shedding based on the E gene was approximately 2.4 days (95% confidence interval [CI], 2.2 to 2.5) and 2.1 days (95% CI, 2.0 to 2.1), respectively. CONCLUSIONS: In one-time tests conducted to diagnose COVID-19 in a large population, although no adjustment for individual characteristics was conducted, it was confirmed that viral shedding differed by the predominant strain and vaccination history. These results show the value of utilizing hundreds of thousands of test data produced at COVID-19 screening test centers.

참고문헌 (47)

  1. "Cases in Korea by city/province"[URL]
  2. Corman VM, "Detection of 2019 novel coronavirus(2019-nCoV)by real-time RT-PCR", Euro Surveill, 25, pp.2000045~ (2020)
  3. Lim AY, "Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea", Int J Infect Dis, 108, pp.428~434 (2021)
  4. Walsh KA, "SARS-CoV-2 detection, viral load and infectivity over the course of an infection", J Infect, 81, pp.357~371 (2020)
  5. He X, "Temporal dynamics in viral shedding and transmissibility of COVID-19", Nat Med, 26, pp.672~675 (2020)
  6. Cevik M, "SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness : a systematic review and meta-analysis", Lancet Microbe, 2, pp.e13~e22 (2021)
  7. Niyonkuru M, "Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report", BMC Infect Dis, 21, pp.743~ (2021)
  8. Huang J, "Epidemiological, virological and serological features of coronavirus disease 2019(COVID-19)cases in people living with human immunodeficiency virus in Wuhan : a population-based cohort study", Clin Infect Dis, 73, pp.e2086~e2094 (2021)
  9. Rogado J, "Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors", Eur J Cancer, 148, pp.58~60 (2021)
  10. Acer Ö, "Association of viral load with age, gender, disease severity, and death in severe acute respiratory syndrome coronavirus 2 variants", J Med Virol, 94, pp.3063~3069 (2022)
  11. Wang Y, "Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China", EClinicalMedicine, 40, pp.101129~ (2021)
  12. Teyssou E, "The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients", J Infect, 83, pp.e1~e3 (2021)
  13. Ong SW, "Clinical and virological features of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)variants of concern : a retrospective cohort study comparing B. 1. 1. 7(Alpha), B. 1. 351(Beta), and B. 1. 617. 2(Delta)", Clin Infect Dis, 75, pp.e1128~e1136 (2022)
  14. Kang M, "Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021", Euro Surveill, 27, pp.2100815~ (2022)
  15. Migueres M, "Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant", J Infect, 84, pp.e7~e9 (2022)
  16. Hay JA, "Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound : a retrospective cohort study", Elife, 11, pp.e81849~ (2022)
  17. Cedro-Tanda A, "Early genomic, epidemiological, and clinical description of the SARS-CoV-2 Omicron variant in Mexico City", Viruses, 14, pp.545~ (2022)
  18. Julin CH, "Household transmission of SARS-CoV-2 : a prospective longitudinal study showing higher viral load and increased transmissibility of the alpha variant compared to previous strains", Microorganisms, 9, pp.2371~ (2021)
  19. Levine-Tiefenbrun M, "Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2", Nat Med, 27, pp.2108~2110 (2021)
  20. Eyre DW, "Effect of Covid-19 vaccination on transmission of alpha and delta variants", N Engl J Med, 386, pp.744~756 (2022)
  21. Singanayagam A, "Community transmission and viral load kinetics of the SARS-CoV-2 delta(B. 1. 617. 2)variant in vaccinated and unvaccinated individuals in the UK : a prospective, longitudinal, cohort study", Lancet Infect Dis, 22, pp.183~195 (2022)
  22. Puhach O, "Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2", Nat Med, 28, pp.1491~1500 (2022)
  23. "Criteria for releasing COVID-19 patients from isolation: scientific brief" (2020)[URL]
  24. "COVID-19 integrated management system"[URL]
  25. "Health and medical crisis response system"[URL]
  26. Muggeo VM, "Estimating regression models with unknown break-points", Stat Med, 22, pp.3055~3071 (2003)
  27. Muggeo VM, "Interval estimation for the breakpoint in segmented regression : a smoothed score-based approach", Aust N Z J Stat, 59, pp.311~322 (2017)
  28. Kim JM, "Increase in viral load in patients with SARS-CoV-2 delta variant infection in the Republic of Korea", Front Microbiol, 13, pp.819745~ (2022)
  29. Takahashi K, "Duration of infectious virus shedding by SARS-CoV-2 Omicron variant-infected vaccinees", Emerg Infect Dis, 28, pp.998~1001 (2022)
  30. Torjesen I, "Covid-19 : peak of viral shedding is later with omicron variant, Japanese data suggest", BMJ, 376, pp.o89~ (2022)
  31. Backer JA, "Shorter serial intervals in SARS-CoV-2 cases with Omicron BA. 1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021", Euro Surveill, 27, pp.2200042~ (2022)
  32. Del Águila-Mejía J, "Secondary attack rate, transmission and incubation periods, and serial interval of SARS-CoV-2 Omicron variant, Spain", Emerg Infect Dis, 28, pp.1224~1228 (2022)
  33. Jansen L, "Investigation of a SARS-CoV-2 B. 1. 1. 529(Omicron)variant cluster-Nebraska, November-December 2021", MMWR Morb Mortal Wkly Rep, 70, pp.1782~1784 (2021)
  34. 기모란, "Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea", Epidemiology and Health, 42, pp.1~7 (2020), 한국역학회[DOI]
  35. Manica M, "Intrinsic generation time of the SARS-CoV-2 Omicron variant : an observational study of household transmission", Lancet Reg Health Eur, 19, pp.100446~ (2022)
  36. Hart WS, "Generation time of the alpha and delta SARS-CoV-2 variants : an epidemiological analysis", Lancet Infect Dis, 22, pp.603~610 (2022)
  37. Mishra B, "High proportion of low cycle threshold value as an early indicator of COVID-19 surge", J Med Virol, 94, pp.240~245 (2022)
  38. Hwang H, "Transmission dynamics of the Delta variant of SARS-CoV-2 infections in South Korea", J Infect Dis, 225, pp.793~799 (2022)
  39. Stankiewicz Karita HC, "Trajectory of viral RNA load among persons with incident SARS-CoV-2 G614 infection(Wuhan strain)in association with COVID-19 symptom onset and severity", JAMA Netw Open, 5, pp.e2142796~ (2022)
  40. Lauring AS, "Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States : prospective observational study", BMJ, 376, pp.e069761~ (2022)
  41. Angel Y, "Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers", JAMA, 325, pp.2457~2465 (2021)
  42. Baden LR, "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine", N Engl J Med, 384, pp.403~416 (2021)
  43. Haas EJ, "Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel : an observational study using national surveillance data", Lancet, 397, pp.1819~1829 (2021)
  44. Pritchard E, "Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom", Nat Med, 27, pp.1370~1378 (2021)
  45. Vasileiou E, "Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland : a national prospective cohort study", Lancet, 397, pp.1646~1657 (2021)
  46. Chia PY, "Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections : a multicentre cohort study", Clin Microbiol Infect, 28, pp.612.e1~612.e7 (2022)
  47. Fall A, "The displacement of the SARS-CoV-2 variant Delta with Omicron : an investigation of hospital admissions and upper respiratory viral loads", EBioMedicine, 79, pp.104008~ (2022)

관련 논문AI추천

Correlation between Clinical Severity and Cycle Threshold Values of Real-time RT-PCR at the Time of Admission in COVID-19 Patients김상경, 유은형, 이아진, 전창호대한진단검사의학회 · Laboratory Medicine Online2023 · 제13권 제4호Clinical severity according to the primary infection variant in patients with suspected SARS-CoV-2 reinfection in Korea김종헌, 황인섭, Hwang Myung-Jae, Park Chungmin, Park Hanul, Son Taejong한국역학회 · Epidemiology and Health2023 · 제45권 Clinical Characteristics of Patients Who Contracted the SARS-CoV-2 Omicron Variant from an Outbreak in a Single Hospital김영근, 김예진, 김은미, 손유진, 오원섭, Pyo Jin Shin연세대학교의과대학 · Yonsei Medical Journal2022 · 제63권 제8호Laboratory Indicators for Convalescence in SARS-CoV-2 Positive Cases With High Ct Value나 래, 김미나, 박근열, 성흥섭대한임상미생물학회 · Annals of Clinical Microbiology2022 · 제25권 제3호SARS-CoV-2 Real-Time RT-PCR 양성 환자에서 추적 PCR 검사 결과 분석Jeon Chang-Ho, Yoo Eun-Hyung대한진단검사의학회 · Laboratory Medicine Online2024 · 제14권 제4호Clinical Performance of the Standard Q COVID-19 Rapid Antigen Test and Simulation of its Real-World Application in KoreaHong Ki Ho, Huh Hee Jae, Kim Namsu, Kim So Yeon, Kim Taek Soo, Lee Hyukmin, Lee Jaehyeon, Roh Kyoung Ho, Sung Heungsup대한진단검사의학회 · Annals of Laboratory Medicine2021 · 제41권 제6호

이 간행물의 다른 논문 (102건)

Changes in health behaviors and obesity of Korean adolescents before and during the COVID-19 pandemic: a special report using the Korea Youth Risk Behavior SurveyChoi Sunhye, Oh Kyungwon, 오창모, Kim Yangha, Yang Ji Eunpp. 1-8Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample황태윤, 오경재, 홍영습, Kim Su Young, 이계오, 윤규현, 김정애, 이혁민, 신민호, 이순영, 이원영, 김동현, 박재현, 이훈재, 조성일, 남해성, 이무식, Lee June-Woo, Kim Sung Soon, 설로마, Kim Byoungguk, 이중정, 오창모, Jung Sun Jae, 오성수, Yim Hyeon Woo, 한미아, 김유미, 조희숙, Lee Ju-Hyung, Jung Jaehun, Kim Ah-Ra, Han Jina, Baek Hye Jin, Noh Eunbi, Ryu Sukhyun, 박노례, Jung Eunok, Kim Sang Il, Hwang Yoo-Sung, Oh Sangcheol, Kim Migyeong, Yu Byengchul, Kim Keonyeop, Hwangbo Young, Lee Joongyub, Kim Hyeongsu, Kang Gilwon, Ryu So Yeon, Park Soon-Woo, Kim Sang Kyu, Park Ki Soo, Kwon Jun-wook, Jang Eun Young, Nam Jeonghyunpp. 1-13Genetically determined alcohol consumption and cancer risk in Korea지선하, 정금지, 백지우, Shin Sang Yoppp. 1-7Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea고미정, 김형준, 황인섭, Kwon Yunhyung, Kim Seontae, Seo Soon-Young, Cho Enhi, Yeon-Kyeng Leepp. 1-7Detecting mpox infection in the early epidemic: an epidemiologic investigation of the third and fourth cases in KoreaChoi Jihyun, Choi Yunsang, Kim Jong Mu, 박숙경, Kim Taeyoung, Park Eonjoo, Eun Juk Suk, Lee Eun-young, Mun Ji Won, Lee Sinyoung, Yeom Hansol, Kim Eun Kyoung, Ha Jinhopp. 1-7
원문 보기